Brochure on REBLOZYL Now Available
August 7, 2020 – Bristol Myers Squibb (BMS) and Acceleron have developed a brochure called “Your Guide to Starting REBLOZYL”. This brochure provides background information about ineffective erythropoiesis in thalassemia, an overview of the clinical trial findings for REBLOZYL/luspatercept in adults with transfusion-dependent beta thalassemia, a listing of the benefits and side effects of REBLOZYL treatment, and an overview of how REBLOZYL is administered. Download the brochure here: https://www.thalassemia.org/wp-content/uploads/2020/08/Your-Guide-to-Starting-REBLOZYL.pdf
CAF provides information of interest to the community. CAF does not imply endorsement of any one product or procedure.